Case Studies

A standardized framework for every patient story.

Every case study follows the same six-section template — so families and clinicians can compare cases fairly, not selectively.

Benefits verified prior to treatment

BCBS·Aetna·Cigna·UnitedHealthcare FDA-cleared TMS

Insurance Accepted

BCBS·Aetna·Cigna·UHC

Google Rating

4.9 / 5.0

Highly Rated by Families in Illinois

Physician Reviewed

Every Treatment Plan

Overseen by a licensed physician

FDA-Cleared TMS

Non-Invasive Therapy

For depression, anxiety, OCD

The Reign-Bow case study framework

Standardization matters. Without a shared template, clinics tend to publish only their most dramatic outcomes. We publish every approved case in the same structure, so what you see is what you get.

Section 1

Presenting concerns

What the family came in with, in plain language — symptoms, daily impact, prior treatments, and goals.

Section 2

qEEG findings

What the 19-channel baseline brain map showed: which regions and networks were over- or under-regulated.

Section 3

Treatment plan & timeline

Targets, protocol, schedule, and week-by-week clinical milestones — physician-signed before treatment began.

Section 4

Progress tracking

Session logs, midpoint parent-report measures, and weekly trend review from the NeuroAxis dashboard.

Section 5

Parent observations

Real, unprompted quotes from the family — included to ground the data in lived experience.

Section 6

Outcome summary

Baseline vs. follow-up metrics, a repeat qEEG comparison, and clinical interpretation of what changed.

Browse cases by focus area

Anonymized cases

  • Communication9 years old·Autism (Level 2), minimally verbal

    Case M.: From 3-word utterances to consistent 5–8 word requests over a 12-week qEEG-guided TMS course.

    Read the full case →
  • Attention8 years old·Autism + co-occurring attention dysregulation

    Case J.: Sustained classroom attention rose from <3 minutes to 18+ minutes after a 10-week protocol.

    Read the full case →
  • Emotional Regulation11 years old·Autism + emotional dysregulation

    Case S.: Meltdown frequency dropped from 6–8 per week to under 1 per week with sustained improvement at 90-day follow-up.

    Read the full case →
  • Sleep7 years old·Autism, chronic insomnia, melatonin non-responder

    Case L.: Sleep onset latency dropped from 90+ minutes to under 20; night wakings from 3–4 to 0–1.

    Read the full case →
  • Executive Function13 years old·Autism with executive function deficits

    Case A.: Independent task initiation rose from rare to consistent, with grade improvement across 3 subjects.

    Read the full case →

Want to know what your child's case might look like?

Verify your insurance benefits or request a consultation — most families hear back within one business day.

Frequently asked questions

Are these real patients?

Yes. Every case is real, pseudonymized, and reviewed by our medical director before publishing. Identifying details are modified for HIPAA compliance.

Why is the framework the same for every case?

A standardized template lets families and referring clinicians compare cases fairly — and prevents cherry-picking the most dramatic outcome metric.

Can my child's outcome look like one of these?

Maybe. Outcomes depend on baseline qEEG, plan adherence, age, and co-occurring factors. Our outcomes page shows the typical range.

Where do these results come from?

Combined session logs, validated parent-report instruments, school reports where applicable, and a follow-up qEEG comparison.